Fagus Antibody Services

Recombinant Human SIGLEC2/CD22 Protein (Fc Tag)

£103.20£375.00 excluding VAT

SKU FAS-033750-P Category

CD22 is a member of the immunoglobulin superfamily; SIGLEC family of lectins. It is first expressed in the cytoplasm of pro-B and pre-B cells; and on the surface as B cells mature to become IgD+. CD22 serves as an adhesion receptor for sialic acid-bearing ligands expressed on erythrocytes and all leukocyte classes. In addition to its potential role as a mediator of intercellular interactions; signal transduction through CD22 can activate B cells and modulate antigen receptor signaling in vitro. The phenotype of CD22-deficient mice suggests that CD22 is primarily involved in the generation of mature B cells within the bone marrow; blood; and marginal zones of lymphoid tissues. CD22 recruits the tyrosine phosphatase Src homology 2 domain-containing phosphatase 1 (SHP-1) to immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and inhibits B-cell receptor (BCR)-induced Ca2+ signaling on normal B cells. CD22 interacts specifically with ligands carrying alpha2-6-linked sialic acids. As an inhibitory coreceptor of the B-cell receptor (BCR); CD22 plays a critical role in establishing signalling thresholds for B-cell activation. Like other coreceptors; the ability of CD22 to modulate B-cell signalling is critically dependent upon its proximity to the BCR; and this in turn is governed by the binding of its extracellular domain to alpha2;6-linked sialic acid ligands. However; genetic studies in mice reveal that some CD22 functions are regulated by ligand binding; whereas other functions are ligand-independent and may only require expression of an intact CD22 cytoplasmic domain at the B-cell surface. CD19 regulates CD22 phosphorylation by augmenting Lyn kinase activity; while CD22 inhibits CD19 phosphorylation via SHP-1.Immune Checkpoint   Immunotherapy   Cancer Immunotherapy   Targeted Therapy

Size

10µg, 50µg

Active Protein
Activity
Protein Construction

Recombinant Human CD22 is produced by our Mammalian expression system and the target gene encoding Asp20-Arg687 is expressed with a Fc tag at the C-terminus.

Sequence

Asp20-Arg687

Fusion Tag

C-Fc

Accession

P20273

Species

Human

Expressed Host

Human Cells

Shipping

This product is provided as lyophilized powder which is shipped with ice packs.

Purity

> 95 % as determined by reducing SDS-PAGE.

Endotoxin

< 1.0 EU per μg as determined by the LAL method.

Stability and Storage

Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Mol Mass

102.3 kDa

AP Mol Mass

130-135 kDa

Formulation

Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 .

Research Areas

Cancer, immunology, Stem cells

Reconstitution

Please refer to the printed manual for detailed information.

Related Product